These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 24486380

  • 1. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain.
    Revilla S, Suñol C, García-Mesa Y, Giménez-Llort L, Sanfeliu C, Cristòfol R.
    Neuropharmacology; 2014 Jun; 81():55-63. PubMed ID: 24486380
    [Abstract] [Full Text] [Related]

  • 2. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Jun; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 3. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
    Mota SI, Ferreira IL, Valero J, Ferreiro E, Carvalho AL, Oliveira CR, Rego AC.
    Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
    [Abstract] [Full Text] [Related]

  • 4. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.
    García-Mesa Y, Pareja-Galeano H, Bonet-Costa V, Revilla S, Gómez-Cabrera MC, Gambini J, Giménez-Llort L, Cristòfol R, Viña J, Sanfeliu C.
    Psychoneuroendocrinology; 2014 Jul; 45():154-66. PubMed ID: 24845186
    [Abstract] [Full Text] [Related]

  • 5. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y, Zhao Y, Dai CL, Liang Z, Run X, Iqbal K, Liu F, Gong CX.
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [Abstract] [Full Text] [Related]

  • 6. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Nov; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of exercise training against the progression of Alzheimer's disease in 3xTg-AD mice.
    Kim D, Cho J, Kang H.
    Behav Brain Res; 2019 Nov 18; 374():112105. PubMed ID: 31325514
    [Abstract] [Full Text] [Related]

  • 8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 9. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L, Scherrmann JM, Farinotti R, Calon F, Bourasset F.
    Neuropharmacology; 2014 Jun 03; 81():311-7. PubMed ID: 24631967
    [Abstract] [Full Text] [Related]

  • 10. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Jun 03; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 11. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
    Clark JK, Furgerson M, Crystal JD, Fechheimer M, Furukawa R, Wagner JJ.
    Neurobiol Learn Mem; 2015 Nov 03; 125():152-162. PubMed ID: 26385257
    [Abstract] [Full Text] [Related]

  • 12. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
    Cadena-del-Castillo C, Valdes-Quezada C, Carmona-Aldana F, Arias C, Bermúdez-Rattoni F, Recillas-Targa F.
    J Alzheimers Dis; 2014 Nov 03; 41(3):845-54. PubMed ID: 24685633
    [Abstract] [Full Text] [Related]

  • 13. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
    Orta-Salazar E, Aguilar-Vázquez A, Martínez-Coria H, Luquín-De Anda S, Rivera-Cervantes M, Beas-Zarate C, Feria-Velasco A, Díaz-Cintra S.
    Life Sci; 2014 Oct 29; 116(2):83-9. PubMed ID: 25261598
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice.
    Chakroborty S, Kim J, Schneider C, West AR, Stutzmann GE.
    J Neurosci; 2015 Apr 29; 35(17):6893-902. PubMed ID: 25926464
    [Abstract] [Full Text] [Related]

  • 15. [Effects of physical exercise on cognitive alterations and oxidative stress in an APP/PSN1 transgenic model of Alzheimer's disease].
    Pareja-Galeano H, Brioche T, Sanchís-Gomar F, Escrivá C, Dromant M, Gómez-Cabrera MC, Viña J.
    Rev Esp Geriatr Gerontol; 2012 Apr 29; 47(5):198-204. PubMed ID: 22884639
    [Abstract] [Full Text] [Related]

  • 16. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T.
    Eur J Neurosci; 2006 Apr 29; 23(8):2035-47. PubMed ID: 16630051
    [Abstract] [Full Text] [Related]

  • 17. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
    Bedse G, Romano A, Cianci S, Lavecchia AM, Lorenzo P, Elphick MR, Laferla FM, Vendemiale G, Grillo C, Altieri F, Cassano T, Gaetani S.
    J Alzheimers Dis; 2014 Apr 29; 40(3):701-12. PubMed ID: 24496074
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F.
    Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781
    [Abstract] [Full Text] [Related]

  • 19. Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer's disease.
    Haskins M, Jones TE, Lu Q, Bareiss SK.
    Neurosci Lett; 2016 Jan 01; 610():165-70. PubMed ID: 26547034
    [Abstract] [Full Text] [Related]

  • 20. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
    Goussakov I, Miller MB, Stutzmann GE.
    J Neurosci; 2010 Sep 08; 30(36):12128-37. PubMed ID: 20826675
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.